The current status of ponatinib in the treatment of chronic myeloid leukemia

Clin Adv Hematol Oncol. 2014 May;12(5):329-31.
No abstract available

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Imidazoles / therapeutic use*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Pyridazines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Imidazoles
  • Pyridazines
  • ponatinib